Clinical Trial Update: Refractory Urge Incontinence and Botox Injections [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating botulinum toxin injections for refractory urge incontinence due to detrusor overactivity was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Detrusor Overactivity
• Overactive Bladder
• Urge Incontinence
• Urinary Incontinence

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Urinary Incontinence, Detrusor Overactivity | Phase 3 | Status: TERMINATED